BUSINESS● LOWJun 23 · Jun 23, 2026, 10:28 AM
Organon and Henlius launch Prolia and Xgeva biosimilars in Canada
Seeking Alpha Tech
Organon and Henlius have launched biosimilars for Prolia and Xgeva in Canada. This marks a new development in the Canadian pharmaceutical market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowAviation: with the takeover of TAP, can Lufthansa challenge Air France-KLM in Africa?Jeune AfriqueBUSINESS23m agoTreasury yields slide as investors flee to safety of bonds amid tech routCNBC